AfroCentric’s JSE Collapse Fuels a New Healthcare Empire
Explore how Sanlam's strategic patience with AfroCentric transforms market neglect into a promising opportunity in healthcare.
Adcock Ingram Delisting After Natco Acquisition
Adcock Ingram delisting from the JSE is confirmed for November 11. Learn about the impact of the Natco Pharma acquisition.